SCHEMBL19862522

SCHEMBL19862522

Oc1c(Cl)cc(Br)cc1/C=N/Nc1ncc2ccccc2n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 11/20 0.58
▸ NPC1 O15118 8/20 0.58
▸ HTT P42858 6/20 0.58
▸ SMN1; SMN2 Q16637 6/20 0.58
▸ MITF O75030 1/20 0.58
▸ ALDH1A1 P00352 1/20 0.58
▸ KMT2A Q03164 11/20 0.50
▸ MAPT P10636 11/20 0.50
▸ MEN1 O00255 9/20 0.50
▸ KDM4E B2RXH2 5/20 0.50
▸ LMNA P02545 2/20 0.47
▸ USP2 O75604 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ GAA P10253 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ HKDC1 Q2TB90 1/20 0.46
▸ KDM4C Q9H3R0 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ PLA2G1B P04054 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13548867 0.82 RAB9A (0.82) RAB9ANPC1HTTSMN1; SMN2MITF
SCHEMBL13548884 0.82 KMT2A (0.60) RAB9ANPC1HTTSMN1; SMN2MITF
SCHEMBL8241328 0.77 DDX3X (0.59) RAB9ANPC1HTTSMN1; SMN2MITF
SCHEMBL4405047 0.72 KDM5A (0.52) RAB9ANPC1HTTSMN1; SMN2MITF
SCHEMBL13548897 0.71 RAB9A (0.52) RAB9ANPC1HTTSMN1; SMN2MITF
SCHEMBL13548896 0.71 KDM5A (0.65) RAB9ANPC1HTTSMN1; SMN2MITF
SCHEMBL4404326 0.71 KDM5A (0.50) RAB9ANPC1HTTSMN1; SMN2MITF
SCHEMBL4411838 0.71 KDM5A (0.65) RAB9ANPC1HTTSMN1; SMN2MITF
SCHEMBL19862523 0.70 RAB9A (0.46) RAB9ANPC1HTTSMN1; SMN2MITF
SCHEMBL26032120 0.68 RAB9A (0.52) RAB9ANPC1HTTSMN1; SMN2MITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180042935-A1 THERAMUTEIN MODULATORS HMI Medical Innovations, LLC 2018-02-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180042935-A1 THERAMUTEIN MODULATORS TSG101, SERPINE1, PLAUR RAB9A 2031/4885NPC1 4410/4885HTT 1926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback